Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Human immunodeficiency virus (HIV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Human immunodeficiency virus (HIV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Human immunodeficiency virus (HIV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 779 of 779 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Sample Detail 1 | Test 2 | Test Data 2 | Sample Detail 2 | Test 3 | Test Data 3 | Sample Detail 3 | Product Details | Price | Buy | Additional Information 1 | Additional Data 1 | Additional Detail 1 | Additional Information 2 | Additional Data 2 | Additional Detail 2 | Additional Information 3 | Additional Data 3 | Additional Information 4 | Additional Data 4 | Additional Information 5 | Additional Data 5 | Additional Detail 5 | Additional Information 6 | Additional Data 6 | Additional Detail 6 | Additional Information 7 | Additional Data 7 | Additional Detail 7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DLS12-8367 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 30 Y | F | U/A | <-70°C | 06-Feb-07 | Abbott Prism | 62.59 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8370 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 24 Y | M | U/A | <-70°C | 19-Feb-07 | Abbott Prism | 5.24 S/Co | HIV | Immunoblot | gp120(-) gp41(2+) 2ENV(-) p31(-) p24(-) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8371 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 34 Y | M | U/A | <-70°C | 11-May-07 | Abbott Prism | 16.88 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(+/-) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8372 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 44 Y | M | U/A | <-70°C | 18-May-07 | Abbott Prism | 15.33 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8373 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 50 Y | M | U/A | <-70°C | 30-Jan-05 | Abbott Prism | 57.62 S/Co | HIV | Immunoblot | gp120(2+) gp41(2+) 2ENV(-) p31(1+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8377 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 40 Y | M | U/A | <-70°C | 23-Mar-05 | Abbott Prism | 123.23 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8379 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 25 Y | M | U/A | <-70°C | 11-Apr-07 | Abbott Prism | 108.89 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8382 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 39 Y | M | U/A | <-70°C | 11-Dec-07 | Abbott Prism | 132.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8384 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 54 Y | F | U/A | <-70°C | 08-Jan-08 | Abbott Prism | 72.79 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8385 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 35 Y | M | U/A | <-70°C | 20-Feb-08 | Abbott Prism | 116.0 S/Co | HIV | Immunoblot | gp120(1+) gp41(4+) 2ENV(-) p31(+/-) p24(1+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8386 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 27 Y | M | U/A | <-70°C | 22-Feb-08 | Abbott Prism | 99.31 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8388 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 31 Y | M | U/A | <-70°C | 22-Oct-09 | Abbott Prism | 86.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8389 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 28 Y | F | U/A | <-70°C | 14-May-10 | Abbott Prism | 140.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8390 | Human immunodeficiency virus (HIV) | Germany | Citrated Plasma | 1.00 | 2.00 | $25.00 | 61 Y | M | U/A | <-70°C | 30-Jun-10 | Abbott Prism | 162.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $25.00 | Co-Infection | Syphilis | ||||||||||||||||||||||||
| DLS12-8391 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 32 Y | M | U/A | <-70°C | 17-Aug-10 | Abbott Prism | 136.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8392 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 40 Y | M | U/A | <-70°C | 08-Sep-10 | Abbott Prism | 162.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8393 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 34 Y | M | U/A | <-70°C | 08-Sep-10 | Abbott Prism | 82.0 S/Co | HIV | Immunoblot | gp120(+/-) gp41(2+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8394 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 22 Y | M | U/A | <-70°C | 08-Sep-10 | Abbott Prism | 153.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8395 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 34 Y | F | U/A | <-70°C | 16-Oct-10 | Abbott Prism | 159.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8397 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 21 Y | M | U/A | <-70°C | 07-Dec-10 | Abbott Prism | 104.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8398 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 46 Y | M | U/A | <-70°C | 11-Dec-10 | Abbott Prism | 128.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8400 | Human immunodeficiency virus (HIV) | Italy | Citrated Plasma | 1.00 | 3.00 | $25.00 | 29 Y | M | U/A | <-70°C | 26-Jan-11 | Abbott Prism | 94.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8401 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 23 Y | M | U/A | <-70°C | 03-Feb-11 | Abbott Prism | 70.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8404 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 27 Y | M | U/A | <-70°C | 10-Mar-11 | Abbott Prism | 167.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8405 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 48 Y | M | U/A | <-70°C | 25-Mar-11 | Abbott Prism | 153.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8406 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 19 Y | M | U/A | <-70°C | 28-Apr-11 | Abbott Prism | 53.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8407 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 19 Y | M | U/A | <-70°C | 19-May-11 | Abbott Prism | 114.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8408 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 32 Y | M | U/A | <-70°C | 24-May-11 | Abbott Prism | 120.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8409 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 26 Y | M | U/A | <-70°C | 30-May-11 | Abbott Prism | 72.0 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(+/-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8410 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 1.00 | $25.00 | 34 Y | M | U/A | <-70°C | 09-Jun-11 | Abbott Prism | 102.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8411 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 34 Y | F | U/A | <-70°C | 03-Jun-11 | Abbott Prism | 72.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(+/-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8412 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 35 Y | M | U/A | <-70°C | 18-Jun-11 | Abbott Prism | 7.55 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(2+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8413 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 24 Y | F | U/A | <-70°C | 21-Jul-11 | Abbott Prism | 126.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8414 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 27 Y | M | U/A | <-70°C | 27-Sep-11 | Abbott Prism | 9.58 S/Co | HIV | Immunoblot | gp120(-) gp41(2+) 2ENV(-) p31(-) p24(+/-) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8415 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 36 Y | M | U/A | <-70°C | 09-Nov-11 | Abbott Prism | 150.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8416 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 26 Y | M | U/A | <-70°C | 05-Dec-11 | Abbott Prism | 96 S/Co | Co-Infection | Syphilis | $25.00 | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(3+) p24(4+) | |||||||||||||||||||||||||
| DLS12-8417 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 45 Y | M | U/A | <-70°C | 13-Jan-12 | Abbott Prism | 111.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8418 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 42 Y | M | U/A | <-70°C | 28-Jan-12 | Abbott Prism | 98.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8419 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 31 Y | M | U/A | <-70°C | 31-Jan-12 | Abbott Prism | 49.0 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(3+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8420 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 50 Y | F | U/A | <-70°C | 23-Feb-12 | Abbott Prism | 90.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(-) p31(4+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8421 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 26 Y | M | U/A | <-70°C | 25-Feb-12 | Abbott Prism | 92.0 S/Co | HIV | Immunoblot | gp120(3+) gp41(4+) 2ENV(+/-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8422 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 42 Y | M | U/A | <-70°C | 29-Feb-12 | Abbott Prism | 86.0 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(-) p24(2+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8423 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 3.00 | $25.00 | 26 Y | M | U/A | <-70°C | 02-Mar-12 | Abbott Prism | 84.0 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(3+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8424 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 38 Y | M | U/A | <-70°C | 04-Apr-12 | Abbott Prism | 116.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8425 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 27 Y | M | U/A | <-70°C | 10-May-12 | Abbott Prism | 84.0 S/Co | HIV | Immunoblot | gp120(+/-) gp41(4+) 2ENV(-) p31(4+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8426 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 24 Y | F | U/A | <-70°C | 07-May-12 | Abbott Prism | 121.0 S/Co | HIV | Immunoblot | gp120(4+) gp41(4+) 2ENV(+/-) p31(2+) p24(4+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8427 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 27 Y | M | U/A | <-70°C | 31-May-12 | Abbott Prism | 131.0 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) 2ENV(-) p31(4+) p24(2+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8428 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 35 Y | F | U/A | <-70°C | 07-Jun-12 | Abbott Prism | 119.0 S/Co | HIV | Immunoblot | Gp120(3+) gp41(4+) 2ENV(-) p31(3+) p24(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8429 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 36 Y | M | U/A | <-70°C | 09-Jul-12 | Abbott Prism | 136.0 S/Co | HIV | Immunoblot | sgp120(3+) gp41(3+) p31(2+) p24(3+) p17(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8430 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 2.00 | $25.00 | 19 Y | M | U/A | <-70°C | 10-Nov-12 | Abbott Prism | 146.5 S/Co | HIV | Immunoblot | gp120(2+) gp41(4+) p31(3+) p24(2+) p17(3+) | $25.00 | ||||||||||||||||||||||||||
| DLS12-8431 | Human immunodeficiency virus (HIV) | Spain | Citrated Plasma | 1.00 | 4.00 | $25.00 | 36 Y | M | U/A | <-70°C | 20-Nov-12 | Abbott Prism | 80.37 S/Co | HIV | Immunoblot | sgp120(2+) gp41(3+) p31(2+) p24(2+) p17(2+) | $25.00 | ||||||||||||||||||||||||||
| DLS13-11694 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 13-Sep-11 | Roche cobas | 759 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 106.590 | Elisa | 24.118 | Innolia | Positive | DGV | Pos | Western Blot INTS | p18 (3+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage), Ac Pos | |||||||||||||||
| DLS13-11699 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 14-Apr-11 | Roche cobas | 2,982 copies/mL | HIV | Genotype: CRF02 | Serotype: C | $40.00 | Elisa | 10.882 | Axsym Combo | 15.970 | Confirmation | Positive | DGV | Pos | Western Blot | p17 (2+); p24 (3+); p31 (3+); gp41 (3+); p66 (3+); sgp120 (3+); gp160 (3+) | Western Blot INTS | p18 (+/-); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+), Ac Pos | |||||||||||||||
| DLS13-11700 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 06-Jun-11 | Roche cobas | 1,528 copies/mL | HIV | Genotype: | CRF02 | Serotype: C | $40.00 | Elisa | 11.916 | Prism | 123.380 | Innolia | Positive | DGV | Pos | Western Blot INTS | p18 (1+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage); Ac Pos | |||||||||||||||
| DLS13-11702 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 4.00 | $40.00 | U/A | U/A | < -70C | 01-Sep-11 | Roche cobas | 964 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 149.480 | Elisa | 12.605 | Innolia | Positive | DGV | Pos | Western Blot INTS | p18 (2+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage), Ac Pos | |||||||||||||||
| DLS13-11704 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 3.00 | $40.00 | U/A | U/A | < -70C | 24-Jan-11 | Roche cobas | 444 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 11.811 | Elisa 2 | 13.246 | Innolia | Positive | DGV | Pos | Western Blot INTS | p18 (2+); p24 (3+); p34 (3+); gp41 (3+); p55 (2+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage); Ac Pos | |||||||||||||||
| DLS13-11705 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 28-Mar-11 | Roche cobas | 416 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 11.450 | Elisa 2 | 14.907 | Innolia | Positive | DGV | Pos | Western Blot INTS | p18 (+/-); p24 (1+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage), Ac Nég | |||||||||||||||
| DLS13-11706 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 12-Nov-10 | Roche cobas | 21,246 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 118.750 | Elisa | 10.729 | Innolia | Positive | DGV | Pos | Western Blot: | p18 (3+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11715 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 16-Nov-10 | Roche cobas | 6,300 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 144.900 | Elisa | 10.753 | DGV | Pos | Western Blot | p18 (3+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||||
| DLS13-11718 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 15-Mar-10 | Roche cobas | 6,261 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 9.967 | Axsym Combo | 11.910 | DGV | Pos | Western Blot | p18 (+++); p24 (++); p34 (+++); gp41 (+); p55 (+); p68 (++); gp120 (++); gp160 (+++) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||||
| DLS13-11720 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 26-Mar-10 | Roche cobas | 8,245 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 152.480 | Elisa | 10.870 | Innolia | Positive | DGV | Pos | Innolia | sgp120 (3+); gp41 (3+); p31 (2+); p24 (2+); p17 (2+). | -Western Blot : P18(1+); P24(3+); P34(3+); GP41(3+); P55(3+); P68(3+); GP120(3+); GP160(3+) -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11721 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 26-Mar-10 | Roche cobas | 16,112 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 99.070 | Elisa | 12.405 | Innolia | Positive | DGV | Pos | Innolia | sgp120 (2+); gp41 (3+); p31 (2+); p24 (2+); p17 (2+) | -Western Blot : P18(3+); P24(3+); P34(3+-); GP41(2+); P55(3+); P68(3+); GP120(2+); GP160(3+) -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11722 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 03-May-10 | Roche cobas | 2,057 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 157.730 | Elisa | 11.289 | Innolia | Positive | DGV | Pos | Innolia | sgp41(3+); gp120 (3+); p31 (2+); p24 (3+); p17 (2+); sgp105 (--); gp36 (--) | -Western Blot : P18(2+); P24(3+); P34(3+); GP41(3+); P55(3+); P68(3+); GP120(3+); GP160(3+) -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11723 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 27-May-10 | Roche cobas | 7,621 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 118.600 | Elisa | 11.167 | Innolia | Positive | DGV | Pos | Innolia | sgp41(4+); gp120 (2+); p31 (2+); p24 (2+); p17 (2+); sgp105 (--); gp36 (--) | -Western Blot : P18(2+); P24(3+); P34(3+); GP41(3+); P55(1+); P68(3+); GP120(3+); GP160(3+) -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11724 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | Roche cobas | 4,044 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Axsym | 24.260 | Elisa | 13.100 | Western Blot | p18 (+++); p24 (+++); p34 (+++); gp41 (+++); p55 (+++); p68 (+++); gp120 (+++); gp160 (+++) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | ||||||||||||||||||||
| DLS13-11727 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 27-Apr-10 | Roche cobas | 18,696 copies/mL | HIV | Genotype: | B | Serotype: A | $40.00 | Prism | 95.140 | Elisa | 11.905 | Innolia | Positive | DGV | Pos | Western Blot | p18 (1+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11728 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 15-Jun-10 | Roche cobas | 6,565 copies/mL | HIV | Genotype: | B | Serotype: NT | $40.00 | Prism | 25.120 | Elisa | 11.321 | Innolia | Positive | DGV | Pos | Innolia | sgp41(2+); gp120 (--); p31 (--); p24 (2+); p17 (1+); sgp105 (--); gp36 (--) | Western Blot | P18(tr); P24(3+); P34(tr); GP41(--); P55(3+); P68(--); GP120(--); GP160(1+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||
| DLS13-11729 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 14-Jun-10 | Roche cobas | 10,657 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 102.770 | Elisa | 10.068 | Innolia | Positive | DGV | Pos | Prism 4th Value | 96,22 | Western Blot | P18(3+); P24(3+); P34(3+); GP41(3+); P55(1+); P68(3+); GP120(3+); GP160(3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||
| DLS13-11730 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 17-Jul-10 | Roche cobas | 2,525 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 10.830 | Elisa 2 | 16.043 | Innolia | Positive | DGV | Pos | Western Blot | p18 (3+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | AgP24 Négatif | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | ||||||||||||||
| DLS13-11731 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 13-Apr-10 | Roche cobas | 27,326 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Prism | 156.920 | Elisa | 10.830 | Innolia | Positive | DGV | Pos | Western Blot | p18 (1+); p24 (3+); p34 (3+); gp41 (3+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-11732 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 31-Aug-10 | Roche cobas | 36,025 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 11.152 | Elisa 2 | 18.025 | Innolia | Positive | DGV | Pos | Western Blot | p18 (2+); p24 (3+); p34 (3+); gp41 (1+); p55 (2+); p68 (3+); gp120 (3+); gp160 (3+) | AgP24 Négatif | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | ||||||||||||||
| DLS13-11733 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 1.00 | $40.00 | U/A | U/A | < -70C | 11-Aug-10 | Roche cobas | 7,036 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 11.364 | Elisa 2 | 15.748 | Innolia | Positive | DGV | Pos | Western Blot | p18 (--); p24 (3+); p34 (3+); gp41 (+/-); p55 (1+); p68 (2+); gp120 (2+); gp160 (2+) | AgP24 Négatif | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | ||||||||||||||
| DLS13-11734 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 18-Oct-10 | Roche cobas | 1,152 copies/mL | HIV | Genotype: | B | Serotype: B | $40.00 | Elisa | 10.563 | Elisa 2 | 14.282 | Innolia | Positive | DGV | Pos | Western Blot | p18 (2+); p24 (3+); p34 (3+); gp41 (2+); p55 (3+); p68 (3+); gp120 (3+); gp160 (3+) | AgP24 Négatif | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | ||||||||||||||
| DLS13-11737 | Human immunodeficiency virus (HIV) | France | Citrated Plasma | 1.00 | 2.00 | $40.00 | U/A | U/A | < -70C | 30-Sep-10 | Roche cobas | 12,514 copies/mL | HIV | Genotype: | B | Serotype: NT | $40.00 | Prism | 61.710 | Elisa | 10.884 | Innolia | Positive | DGV | Pos | Western Blot | p18 (+/-); p24 (3+); p34 (1+); gp41 (tr); p55 (2+); p68 (1+); gp120 (1+); gp160 (2+) | -COBAS Taqman HIV-1 (PCR - Virémie) -Séquençage Gène Env (Génotypage) -Technique ommuno-Enzymatique SSEIA-V3 (Serotypage) | |||||||||||||||
| DLS13-16958 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 54 Y | M | U/A | < -70C | 21-Mar-11 | Roche Amplicor | U/A | HIV | CD4 Result | 495 K/uL | $40.00 | Acquired Infection Category | IV Drug Abuse | Current AIDS Symptoms | History of proteinuria & hypercholesterol, cataract surgery to right eye, HTN, uveitis, glaucoma, G6PD deficient, recurrent abcesses on face & neck | Co-Infections | Hepatitis C, history of neurosyphilis | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Zerit, Ziagen, Viracept | ||||||||||||||||||
| DLS13-16959 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 14.00 | $40.00 | 48 Y | M | U/A | < -70C | 03-Mar-11 | Roche Amplicor | 37 copies/mL | HIV | CD4 Result | 398 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | PML - current, CAP - 2/2011, past DVT & PE (recurrent) | Co-Infections | Hepatitis C | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Lexiva, Norvir, Isentress, Zerit, Epivir | ||||||||||||||||||
| DLS13-16960 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $40.00 | 36 Y | M | U/A | < -70C | 14-Mar-11 | Roche Amplicor | 69 copies/mL | HIV | CD4 Result | 510 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | CAP - 7/27/07, dermatophytosis of nails - 12/20/10, molluscum contagiosum - 9/11/09, thrush - 9/11/09 | Co-Infections | HPV - 7/27/07, tinea cruris - 7/27/07, syphilis - 1990 | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Atripla | ||||||||||||||||||
| DLS13-16962 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 11.00 | $40.00 | 53 Y | F | U/A | < -70C | 21-Mar-11 | Roche Amplicor | 41 copies/mL | HIV | CD4 Result | 619 K/uL | $40.00 | Acquired Infection Category | Unknown | Current AIDS Symptoms | Nuclear sclerotic cataract bilat, myopial presbyopia, osteopenia, hyperlipidemia, HTN, low Vitamin D, release of left trigger thumb | Co-Infections | No co-infections | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Emtricitabine, Kaletra, Invirase | ||||||||||||||||||
| DLS13-16963 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 7.00 | $40.00 | 48 Y | M | U/A | < -70C | 03-Mar-11 | Roche Amplicor | 138 copies/mL | HIV | CD4 Result | 331 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | PCP - 01/2006, CAP - 12/2006 | Co-Infections | No co-infections | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Lexiva, Truvada | ||||||||||||||||||
| DLS13-16964 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 11.00 | $40.00 | 48 Y | F | U/A | < -70C | 17-Mar-11 | Roche Amplicor | 58 copies/mL | HIV | CD4 Result | 617 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Cocaine abuse, Vitamin D deficiency | Co-Infections | Hepatitis C; syphilis & chlamydia history, syphilis titer increasing 11/3/10, trichomonas + | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Isentress, Truvada | ||||||||||||||||||
| DLS13-16966 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $40.00 | 45 Y | M | U/A | < -70C | 14-Mar-11 | Roche Amplicor | 44 copies/mL | HIV | CD4 Result | 574 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No Symptoms | Co-Infections | Hepatitis B | Anti-Retroviral Therapy (ART or HAART) Drugs | Currently taking ART; Drugs: Atripla, Ziagen | ||||||||||||||||||
| DLS13-17040 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $38.00 | 37 Y | M | Black | < -70C | 9/2/2011 | Ortho Genetic Systems HIV-1/2 Plus O | >10.000 S/Co | HIV | Ortho Genetic Systems HIV-1/2 Plus O | S/Co >10.000 | Ortho Genetic Systems HIV-1/2 Plus O | S/Co >10.000 | $38.00 | HIV IFA | Positive | dHIV | S/Co 29.95 | ||||||||||||||||||||
| DLS13-17043 | Human immunodeficiency virus (HIV) | USA | CPD | 1.00 | 1.00 | $38.00 | 23 Y | M | U/A | < -70C | 7/6/2011 | Ortho Genetic Systems HIV-1/2 Plus O | 10.114 S/Co | HIV | Ortho Genetic Systems HIV-1/2 Plus O | S/Co >10.000 | Ortho Genetic Systems HIV-1/2 Plus O | S/Co >10.000 | $38.00 | HIV IFA | Positive | dHIV | S/Co 20.08 | ||||||||||||||||||||
| DLS13-17056 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $40.00 | 54 Y | M | U/A | < -70C | 17-Mar-11 | Roche Amplicor | 228 copies/mL | HIV | CD4 Result | 978 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Hyperlipidemia, alcohol abuse, increased liver enzymes, gout | Co-Infections | No co-infections | Current Medications | Currently taking ART; Drugs: Atripla | ||||||||||||||||||
| DLS13-17057 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 39 Y | F | U/A | < -70C | 03-Mar-11 | Roche Amplicor | 63 copies/mL | HIV | CD4 Result | 647 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Giant cell tumor of spine - 1/2004 | Co-Infections | Hepatitis C; syphilis | Current Medications | Currently taking ART; Drugs: Atripla | ||||||||||||||||||
| DLS13-17059 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $40.00 | 62 Y | M | U/A | < -70C | 02-Mar-11 | Roche Amplicor | 138 copies/mL | HIV | CD4 Result | 905 K/uL | $40.00 | Acquired Infection Category | Transfusion | Current AIDS Symptoms | No Symptoms | Co-Infections | Hepatitis A + 1/8/10 | Current Medications | Currently taking ART; Drugs: Atripla | Slight hemolysis on one tube | |||||||||||||||||
| DLS13-17060 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 6.00 | $40.00 | 64 Y | M | U/A | < -70C | 21-Mar-11 | Roche Amplicor | 56 copies/mL | HIV | CD4 Result | 584 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Polio, schorrheic dermatitis, onychomycosis, PCP, hammer toes, remote subdural hematoma, glaucoma, squamous cell cancer (lip), smoking, multiple actinic keratosis, hyperlipidemia, HIV encyphalitis, AID dementia complex, fat redistribution, mild chronic bronchitis, manic depressive disorder | Co-Infections | Hepatitis B | Current Medications | Currently taking ART; Drugs: Viread, Reyataz, Norvir, Sustiva | ||||||||||||||||||
| DLS13-17062 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 9.00 | $40.00 | 53 Y | M | U/A | < -70C | 21-Mar-11 | Roche Amplicor | 59 copies/mL | HIV | CD4 Result | 141 K/uL | $40.00 | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Hx of lymphoma, prostatitis, osteopenia, extrasystole, mild renal insufficiency, syphilis, PCP - 10/2003, hyperlipidemia, low Vitamin D | Co-Infections | Hx of syphilis | Current Medications | Currently taking ART; Drugs: Emtriva, Norvir, Prezista, Isentress, Intelence | ||||||||||||||||||
| DLS14-21748 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 32 Y | F | Vietnamese | < -70C | 02-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21749 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 36 Y | F | Vietnamese | < -70C | 02-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21750 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 40 Y | M | Vietnamese | < -70C | 02-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21751 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 37 Y | M | Vietnamese | < -70C | 02-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21752 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 36 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21754 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21755 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 36 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21756 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 45 Y | M | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21757 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 31 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21758 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 50 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21761 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 29 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21762 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21763 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 34 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21764 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 45 Y | F | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21765 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | < -70C | 10-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21768 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 32 Y | M | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21770 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 29 Y | F | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21773 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 34 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21774 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 34 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21775 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 32 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21776 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 38 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21778 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 26 Y | F | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21779 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 34 Y | F | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21780 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 31 Y | F | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21782 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21783 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 5 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21785 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 26 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21786 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 10 Y | F | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21787 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21788 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21789 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | M | Vietnamese | < -70C | 30-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21791 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | M | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21792 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 31 Y | F | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21793 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | F | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21795 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 30 Y | F | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21798 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21800 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21801 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 30 Y | M | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-21802 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 43 Y | M | Vietnamese | < -70C | 09-Oct-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-27542 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 10.00 | $50.00 | 41 Y | F | Black | < -70C | 22-Dec-14 | Siemens Trugene | No resistance | 23-Jul-14 | Beckman Coulter CD4 Result | 4 | 17-Dec-14 | Roche Amplicor RT-PCR | 14,984 cps/mL | 17-Dec-14 | $50.00 | HIV Test Results | Last Positive Test Oct-2003 Test - Unknown Subject seropositive 13-years | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Diarrhea (Esophageal candida on 3-Sep-2014 and 16-Oct-2014) | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Dolutegravir, Truvada | |||||||||||
| DLS14-27547 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $50.00 | 49 Y | M | Black | < -70C | 15-Dec-14 | Siemens Trugene | No mutations | 6-Aug-14 | Beckman Coulter CD4 Result | 72 | 22-Jan-14 | Roche Amplicor RT-PCR | 34,817 cps/mL | 6-Aug-14 | $50.00 | HIV Test Results | Last Positive Test 20-Sep-2011 Test - Unknown Subject seropositive 3 years (from prison record) (patient says since 2002) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | IV Drug Abuse | Current AIDS Symptoms | No | Current Co-Infections | Hepatitis C 30-Oct-2013 Stable | Anti-Retroviral Therapy (Currently taking ART) | No | |||||||||||
| DLS14-27548 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 7.00 | $50.00 | 51 Y | M | White | < -70C | 05-Jan-15 | Siemens Trugene | RT - K103N, V108I, M184V, T215S, P225H | 28-Jan-11 | Beckman Coulter CD4 Result | 295 | 23-Sep-14 | Roche Amplicor RT-PCR | 323 cps/mL | 23-Sep-14 | $50.00 | HIV Test Results | Last Positive Test 14-Jan-2004 Test - Unknown Subject seropositive 10.5 years (per MD note) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | IV Drug Abuse | Current AIDS Symptoms | Fatigue; Diarrhea | Current Co-Infections | Chronic Hepatitis B; Hepatitis C Subtype 1; Hep A Ab+ | Anti-Retroviral Therapy (Currently taking ART) | Yes; Atazanavir, Didanosine, Ritonavir, Tenofovir | |||||||||||
| DLS14-27549 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 50 Y | F | Black | < -70C | 22-Dec-14 | Siemens Trugene | RT-M4IL, V90l, A98G, K103N, Y181C, T215Y, PR-L10I, A71V, L90M | 15-Jul-14 | Beckman Coulter CD4 Result | 122 | 12-Nov-14 | Roche Amplicor RT-PCR | 3,899 cps/mL | 12-Nov-14 | $50.00 | HIV Test Results | Last Positive Test 9-Mar-2011 Test - HIV 1/0/2 Abs Subject seropositive 3-years | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | STI: HPV-16+, HPV - non 16/18+ 05-Dec-2014 Roche COBAS HPV test | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Dolutegravir, Truvada | Drug Resistance Testing | PhenoSense Integrase Result: Sensitive to All 22-Jan-2014 | |||||||||
| DLS14-27550 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $50.00 | 31 Y | F | Black | < -70C | 22-Dec-14 | Siemens Trugene | No resistance | 12-Apr-11 | Beckman Coulter CD4 Result | 361 | 17-Dec-14 | Roche Amplicor RT-PCR | 678 cps/mL | 17-Dec-14 | $50.00 | HIV Test Results | Last Positive Test Jun-2009 Test - Unknown Subject seropositive 5 years (per MD note) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Ritonavir, Truvada | |||||||||||
| DLS14-27551 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 4.00 | $50.00 | 45 Y | M | Black | < -70C | 09-Dec-14 | Siemens Trugene | RT-T69N | 27-May-14 | Beckman Coulter CD4 Result | 22 | 25-Nov-14 | Roche Amplicor RT-PCR | 26,014 cps/mL | 25-Nov-14 | $50.00 | HIV Test Results | Last Positive Test 1990 Test - Unknown Subject seropositive 24 years (per patient) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | Yes; Atazanavir, Stribild | Drug Resistance Testing | PhenoSense Integrase Result: Sensitive to All 27-May-2014 | |||||||||
| DLS14-27557 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 8.00 | $50.00 | 52 Y | M | Black | < -70C | 09-Dec-14 | Siemens Trugene | N/A | Beckman Coulter CD4 Result | 43 | 21-Nov-14 | Roche Amplicor RT-PCR | 104,351 cps/mL | 21-Nov-14 | $50.00 | HIV Test Results | Last Positive Test 1999 Test - Unknown Subject seropositive 15 years (per patient) | Diagnostic Status | AIDS | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Secretory diarrhea | Current Co-Infections | Chronic Hepatitis C | Anti-Retroviral Therapy (Currently taking ART) | Yes; Atazanavir, Truvada, Ritonavir | ||||||||||||
| DLS14-27560 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $50.00 | 56 Y | F | Black | < -70C | 08-Dec-14 | Siemens Trugene | RT-L100I, V179D, M184V PR-A71T | 8-Jan-14 | Beckman Coulter CD4 Result | 153 | 15-Oct-14 | Roche Amplicor RT-PCR | 5,187 cps/mL | 15-Oct-14 | $50.00 | HIV Test Results | Last Positive Test 20-Aug-2008 Test - Oraquick Subject seropositive 6 years | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Shingles 26-Nov-2014 | Current Co-Infections | Hepatitis B | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Truvada, Ritonavir | Drug Resistance Testing | PhenoSense Integrase Result: Sensitive to Dolutegravir, Elvitegravir, Raltegravir | |||||||||
| DLS14-27563 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $50.00 | 46 Y | F | Black | < -70C | 08-Dec-14 | Siemens Trugene | No resistance | 4-Aug-14 | Beckman Coulter CD4 Result | 256 | 4-Aug-14 | Roche Amplicor RT-PCR | 28,108 cps/mL | 4-Aug-14 | $50.00 | HIV Test Results | Last Positive Test 22-Jun-2008 Test - Western Blot Subject seropositive 6 years | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Lymphadenopathy 4-Aug-2014 Microcytic anemia 04-Dec-2014 | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | No | |||||||||||
| DLS14-27567 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 6.00 | $50.00 | 54 Y | M | Black | < -70C | 09-Dec-14 | Siemens Trugene | RT-K103N, Y181C, L210W, T215D | 29-Jan-14 | Beckman Coulter CD4 Result | 131 | 30-Oct-14 | Roche Amplicor RT-PCR | 582 cps/mL | 30-Oct-14 | $50.00 | HIV Test Results | Last Positive Test 2002 Test - Unknown Subject seropositive 12 years (per patient) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | Chronic Hepatitis C | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Truvada, Ritonavir, Etravirine, Raltegravir | Drug Resistance Testing | PhenoSense Integrase Result: Sensitive to All 3 12-Mar-2014 | |||||||||
| DLS14-27568 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $50.00 | 33 Y | F | Black | < -70C | 09-Dec-14 | Siemens Trugene | RT-K103N, P225H | 3-Dec-12 | Beckman Coulter CD4 Result | 276 | 16-Oct-14 | Roche Amplicor RT-PCR | 5,005 cps/mL | 16-Oct-14 | $50.00 | HIV Test Results | Last Positive Test 2005 Test - Unknown Subject seropositive 9 years (per patient) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | Yes; Truvada, Raltegravir | Drug Resistance Testing | PhenoSense Integrase Result: Sensitive to Raltegravir and Elvitegravir | |||||||||
| DLS14-27581 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 5.00 | $50.00 | 47 Y | F | Black | < -70C | 16-Dec-14 | Siemens Trugene | RT-T215C, PR-A71T, L90M | 11-May-11 | Beckman Coulter CD4 Result | 357 | 7-Nov-14 | Roche Amplicor RT-PCR | 7,854 cps/mL | 7-Nov-14 | $50.00 | HIV Test Results | Last Positive Test 1996 Test - Unknown Subject seropositive 18 years (per MD note) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | No | |||||||||||
| DLS14-27583 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 60 Y | F | Black | < -70C | 16-Dec-14 | Siemens Trugene | PR-M36I | 20-Oct-14 | Beckman Coulter CD4 Result | 544 | 20-Oct-14 | Roche Amplicor RT-PCR | 20,850 cps/mL | 20-Oct-14 | $50.00 | HIV Test Results | Last Positive Test 8-Oct-2014 Test - HIV Ag/Ab Combo Subject seropositive 2 months | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Fatigue; Abdominal pain; Cramping; Diarrhea; Headaches | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | No | |||||||||||
| DLS14-27559 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 9.00 | $50.00 | 54 Y | F | Black | < -70C | 06-Feb-15 | Siemens Trugene | RT-D67N, T69D, K101E, H208Y, K219Q | 27-Oct-14 | Beckman Coulter CD4 Result | 80 | 17-Dec-14 | Most Recent Viral Load (Roche Amplicor) | 62,090 copies/mL | 17-Dec-14 | $50.00 | Last Positive HIV Test | May-04 | Test - Unknown; Subject seropositive 11 years (MD notes) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | HCV +; HPV +; HAV total Ab + | 2014; 2010; 2014 | Anti-Retroviral Therapy (Currently taking ART) | Yes; Raltegravir, Ritonavir, Rilpivirine | Drug Resistance Testing | PhenoSense Integrase; Result: Sensitive to All | 27-Oct-14 | ||||||
| DLS14-27561 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 10.00 | $50.00 | 52 Y | F | Black | < -70C | 05-Feb-15 | Siemens Trugene | PR-K20R, M36I | 27-Feb-14 | Beckman Coulter CD4 Result | 32 | 27-Feb-14 | Most Recent Viral Load (Roche Amplicor) | 90,268 copies/mL | 27-Feb-14 | $50.00 | Last Positive HIV Test | 1988 | Test - Unknown; Subject seropositive 27 years (MD notes) | Diagnostic Status | HIV Seropositive; AIDS | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Tenofovir, Ritonavir, Zidovudine | Drug Resistance Testing | N/A | ||||||||
| DLS14-27564 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 4.00 | $50.00 | 40 Y | M | Black | < -70C | 05-Feb-15 | Siemens Trugene | RT-M41L, K103N | 9-Jan-14 | Beckman Coulter CD4 Result | 24 | 13-Nov-14 | Most Recent Viral Load (Roche Amplicor) | 118,544 copies/mL | 13-Nov-14 | $50.00 | Last Positive HIV Test | 6-Aug-08 | Test - Unknown; Subject seropositive 7 years (MD notes) | Diagnostic Status | HIV Seropositive; AIDS | Acquired Infection Category | Unknown | Current AIDS Symptoms | Yes; Nausea | Current Co-Infections | Syphilis + | 2014 | Anti-Retroviral Therapy (Currently taking ART) | Yes; Atazanavir, Truvada | Drug Resistance Testing | N/A | |||||||
| DLS14-27566 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 12.00 | $50.00 | 38 Y | M | Black | < -70C | 05-Feb-15 | Siemens Trugene | RT-V106I, PR-M36I | 22-Jan-13 | Beckman Coulter CD4 Result | 106 | 14-Jan-15 | Most Recent Viral Load (Roche Amplicor) | 34,500 copies/mL | 14-Jan-15 | $50.00 | Last Positive HIV Test | 21-Jan-13 | Test -Oraquick; Subject seropositive 2 years | Diagnostic Status | HIV Seropositive; AIDS | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Yes; Abnormal U/A | Current Co-Infections | Hep A +; Syphilis; Disseminated Pulmonary MAC | 2015; 2013; 2013 | Anti-Retroviral Therapy (Currently taking ART) | Yes; Truvada, Ritonavir | Drug Resistance Testing | N/A | |||||||
| DLS14-27574 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 14.00 | $50.00 | 60 Y | M | Black | < -70C | 02-Feb-15 | Siemens Trugene | PR-L10V, K20T, A71I, L90M, RT-M41L, M184V, H208Y, L210W, T215Y | 22-Oct-13 | Beckman Coulter CD4 Result | 85 | 16-Dec-13 | Most Recent Viral Load (Roche Amplicor) | 92,979 copies/mL | 16-Dec-13 | $50.00 | Last Positive HIV Test | 21-Jan-03 | Test - Unknown; Subject seropositive 12 years | Diagnostic Status | HIV Seropositive; AIDS | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | Yes; Diarrhea | Current Co-Infections | N/A | Anti-Retroviral Therapy (Currently taking ART) | Yes; Darunavir, Etravirine, Maraviroc, Ritonavir | Drug Resistance Testing | PhenoSense Integrase; Result: Sensitive to All | 22-Oct-13 | |||||||
| DLS14-27582 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 6.00 | $50.00 | 64 Y | F | Black | < -70C | 13-Jan-15 | Siemens Trugene | RT-D67N, K70NR, M184V, K219Q; PR - D30N, M46L, A71I/T/V | HIV | Beckman Coulter CD4 Result | 567 | 17-Jul-14 | Most Recent Viral Load (Roche Amplicor) | 1,800 copies/mL | 17-Jul-14 | $50.00 | Last Positive HIV Test | 2007 | Test - Unknown; Subject seropositive 7 years (per MD note) | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | Hepatitis C; Alcohol abuse | Anti-Retroviral Therapy (Currently taking ART) | Yes; Dolutegravir, Abacavir, Tenofovir | Drug Resistance Testing | N/A | ||||||||
| DLS14-22127 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 29 Y | M | Vietnamese | <-70C | 12-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22128 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22129 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22130 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22131 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.60 | 1.00 | $50.00 | 34 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22132 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22133 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.60 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22134 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22135 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22136 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22137 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22138 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22139 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.20 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22140 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22141 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22142 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22143 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22144 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22145 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22146 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22147 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 42 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22148 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22149 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22150 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22151 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22152 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22153 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22154 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22155 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22156 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22157 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22158 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 46 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22159 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 11 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22160 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 8 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22161 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 14 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22163 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 12 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22164 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 8 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22165 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 12 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22166 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.50 | 1.00 | $50.00 | 15 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22167 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 12 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22168 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 5 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22169 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 10 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22170 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 15 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22171 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 12 Y | F | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22172 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 12 Y | M | Vietnamese | <-70C | 20-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22173 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22174 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22175 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22176 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 28 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22177 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22178 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22179 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22180 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22181 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22182 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 46 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22183 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 48 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22184 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 51 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22185 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22186 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22187 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22188 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22189 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22190 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22191 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22192 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22193 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22194 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22195 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 46 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22196 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 28 Y | F | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22197 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.60 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22198 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.60 | 1.00 | $50.00 | 19 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22199 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22200 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.80 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22201 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.70 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 20-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22202 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.60 | 1.00 | $50.00 | 63 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22203 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.70 | 1.00 | $50.00 | 38 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22204 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22205 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22206 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22207 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22208 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22209 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22210 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22211 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 52 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22212 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22213 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-27552 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 9.00 | $95.00 | 36 Y | F | Black | <-70C | 06-Feb-15 | Roche Amplicor | 2,919 copies/mL | 29-Jan-15 | Most Recent CD4 Results | 215 cells/uL | 23-Jan-15 | Siemens Trugene | PR-K20R | 29-Jan-15 | $95.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Hepatitis C | Currently Taking ART | Yes | Current Drug Therapy | Atripla | ||||||||||
| DLS14-21052 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 23 Y | M | Hispanic | <-70C | 30-May-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 21.83 | |||||||||||||||||||||
| DLS14-21053 | Human immunodeficiency virus (HIV) | USA | CPD | 1.00 | 2.00 | $25.00 | 22 Y | M | U/A | <-70C | 01-Aug-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | NAT R but QNS for discrim testing | |||||||||||||||||||||
| DLS14-21055 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 30 Y | F | White | <-70C | 31-Jan-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 78.90 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 86.83 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 85.43 | $25.00 | HIV IFA | Not Tested | dHIV S/CO | 21.36 | |||||||||||||||||||||
| DLS14-21058 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 19 Y | M | White | <-70C | 24-Apr-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 27.97 | |||||||||||||||||||||
| DLS14-21059 | Human immunodeficiency virus (HIV) | USA | CPD | 1.00 | 2.00 | $25.00 | 19 Y | M | White | <-70C | 08-May-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 9.939 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 23.63 | |||||||||||||||||||||
| DLS14-21060 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 1.00 | $25.00 | 49 Y | F | Indian | <-70C | 10-Apr-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 113.82 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 95.40 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 90.97 | $25.00 | HIV IFA | Not Tested | dHIV S/CO | 19.14 | |||||||||||||||||||||
| DLS14-21063 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 21 Y | M | Hispanic | <-70C | 11-Jun-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 135.63 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 112.69 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 107.99 | $25.00 | HIV IFA | Not Tested | dHIV S/CO | 21.17 | |||||||||||||||||||||
| DLS14-21064 | Human immunodeficiency virus (HIV) | USA | ACD-A | 1.00 | 2.00 | $25.00 | 34 Y | M | Black | <-70C | 20-Oct-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 17.79 | |||||||||||||||||||||
| DLS14-21065 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 34 Y | M | Black | <-70C | 04-Apr-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 9.623 | $25.00 | HIV IFA | Positive | dHIV S/CO | 28.26 | |||||||||||||||||||||
| DLS14-21067 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 54 Y | F | Hispanic | <-70C | 04-Mar-12 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 29.91 | |||||||||||||||||||||
| DLS14-21069 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 2.00 | $25.00 | 51 Y | F | White | <-70C | 26-Mar-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 27.29 | |||||||||||||||||||||
| DLS14-21079 | Human immunodeficiency virus (HIV) | USA | CPD | 1.00 | 2.00 | $25.00 | 21 Y | M | White | <-70C | 03-Jun-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 32.10 | |||||||||||||||||||||
| DLS14-21082 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 3.00 | $25.00 | 49 Y | M | White | <-70C | 12-Apr-13 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | >10.000 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | >10.000 | $25.00 | HIV IFA | Positive | dHIV S/CO | 0.62 (NR) | |||||||||||||||||||||
| DLS14-21083 | Human immunodeficiency virus (HIV) | USA | CP2D | 1.00 | 3.00 | $25.00 | 40 Y | M | U/A | <-70C | 26-Jul-14 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 1 | 123.82 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 2 | 131.55 | Ortho Genetic Systems HIV-1/2 Plus O S/CO 3 | 125.95 | $25.00 | HIV IFA | Not Tested | dHIV S/CO | 22.98 | |||||||||||||||||||||
| KH15-2269 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 58 Y | M | Black | < -70C | 25-Jun-13 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2281 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 4 M | M | Black | < -70C | 29-Nov-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2294 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 46 Y | F | Black | < -70C | 08-May-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2295 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 19 Y | F | Black | < -70C | 21-Aug-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2297 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 22 Y | F | U/A | < -70C | 10-Jul-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2300 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | U/A | < -70C | 10-Oct-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2302 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 55 Y | F | White | < -70C | 11-Jul-13 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2303 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 38 Y | F | U/A | < -70C | 01-Mar-13 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2305 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 21 Y | M | U/A | < -70C | 19-Oct-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2306 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 43 Y | F | U/A | < -70C | 05-Mar-13 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2307 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | U/A | < -70C | 14-Mar-13 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-2308 | Human immunodeficiency virus (HIV) | USA | EDTA Plasma | 1.00 | 1.00 | $50.00 | 24 Y | M | U/A | < -70C | 21-Dec-12 | Roche Amplicor | <50 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-22231 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22232 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22233 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22234 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22235 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22236 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22237 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22238 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22239 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22240 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22241 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22242 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22243 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22244 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22245 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 18 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22246 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22247 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22248 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 40 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22249 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22250 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 43 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22251 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22252 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22253 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22254 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22255 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 8 Y | M | Vietnamese | <-70C | 20-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22256 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 20-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22257 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | F | Vietnamese | <-70C | 20-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22258 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | F | Vietnamese | <-70C | 20-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22259 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | F | Vietnamese | <-70C | 20-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22260 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 13 Y | F | Vietnamese | <-70C | 20-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22261 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | F | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | |||||||||||||||||||||||||||
| DLS14-22262 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | |||||||||||||||||||||||||||
| DLS14-22263 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | |||||||||||||||||||||||||||
| DLS14-22264 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | F | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22265 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 28 Y | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22266 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22267 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | F | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22268 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22269 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22270 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22271 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 24-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22272 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22273 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 26-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22274 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22276 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | F | Vietnamese | <-70C | 29-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22277 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 29-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | |||||||||||||||||||||||||||
| DLS14-22279 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 10 Y | M | Vietnamese | <-70C | 29-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22280 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 48 Y | M | Vietnamese | <-70C | 30-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22281 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | F | Vietnamese | <-70C | 30-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22283 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 26-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22284 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22285 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 11 Y | F | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22286 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 42 Y | M | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22287 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22288 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22289 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22290 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22291 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 23-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22292 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22293 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22294 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22295 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22296 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22297 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22298 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 42 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22299 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22300 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 27 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22301 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22302 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22303 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22304 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22305 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22306 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 49 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22307 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22308 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22309 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22310 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | F | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22311 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 21-Jan-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22312 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 07-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22313 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 07-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22314 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 07-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22315 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 07-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22316 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 07-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22317 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 07-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22318 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | F | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22319 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 50 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22320 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22321 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 15 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22322 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22323 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22324 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22325 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22326 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22327 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22328 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22329 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22330 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22331 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22332 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 14 Y | F | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22333 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 20-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22334 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22335 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22336 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | |||||||||||||||||||||||||||
| DLS14-22337 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22338 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22339 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22340 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22341 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 53 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22342 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22343 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22344 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22345 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22346 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 54 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22347 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22348 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22349 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | |||||||||||||||||||||||||||
| DLS14-22350 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 34 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22351 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.50 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 21-Mar-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22352 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22354 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-22356 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 26-Dec-14 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23009 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23012 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | F | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23013 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | M | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23014 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23015 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | F | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23016 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| DLS14-23017 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 53 Y | F | Vietnamese | <-70C | 13-Apr-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | Fujirebio SERODIA HIV-1/2 | Positive | $50.00 | ||||||||||||||||||||||||||
| KH15-10496 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 53 Y | M | White | <-70C | 10-Aug-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-10497 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 45 Y | M | White | <-70C | 07-Aug-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-12400 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 71 Y | M | White | <-70C | 31-Aug-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS15-34192 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 1.00 | $95.00 | 37 Y | F | U/A | <-70C | 06-Aug-15 | Roche cobas | 14,277 copies/mL | HIV | $95.00 | ||||||||||||||||||||||||||||
| DLS15-34199 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $95.00 | 39 Y | F | U/A | <-70C | 06-Aug-15 | Roche cobas | 13,810 copies/mL | HIV | $95.00 | ||||||||||||||||||||||||||||
| DLS14-23086 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23087 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 6 Y | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23088 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 7 Y | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23089 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 11 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23090 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | |||||||||||||||||||||||||||||
| DLS14-23091 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | |||||||||||||||||||||||||||||
| DLS14-23092 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 14 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23093 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 6 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23095 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 16 Y | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23096 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 15 Y | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23097 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | F | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23098 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23100 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23101 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 52 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23102 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 46 Y | M | Vietnamese | <-70C | 14-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23103 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23104 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 64 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23105 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23106 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23107 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23108 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 59 Y | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23109 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23110 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 56 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23111 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23112 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23113 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23114 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23115 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23116 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 52 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23118 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 50 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23119 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23120 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23121 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 40 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23122 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 29 Y | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23124 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23125 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | |||||||||||||||||||||||||||||
| DLS14-23126 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23128 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 41 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23131 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | F | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23133 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23135 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 26 Y | M | Vietnamese | <-70C | 15-May-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23137 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23138 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23139 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23140 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | |||||||||||||||||||||||||||||
| DLS14-23141 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | |||||||||||||||||||||||||||||
| DLS14-23142 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23143 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | |||||||||||||||||||||||||||||
| DLS14-23144 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23145 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23146 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23147 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23148 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23149 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 42 Y | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23150 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 34 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23151 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 32 Y | M | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23152 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 26 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23154 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | F | Vietnamese | <-70C | 07-Aug-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23156 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 0.75 | 1.00 | $50.00 | 51 Y | F | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23157 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | F | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23160 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23162 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | M | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23164 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23166 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 14 Y | F | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23167 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 10 Y | M | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS14-23168 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 13 Y | F | Vietnamese | <-70C | 12-Jun-15 | Abbott Murex HIV Ag/Ab Combo | Positive | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-12796 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 55 Y | M | Black | <-70C | 12-Sep-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-13342 | Human immunodeficiency virus (HIV) | USA | Serum | 1.50 | 1.00 | $50.00 | 62 Y | F | White | <-70C | 17-Sep-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-13344 | Human immunodeficiency virus (HIV) | USA | Serum | 1.25 | 1.00 | $50.00 | 23 Y | M | Black | <-70C | 17-Sep-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-13345 | Human immunodeficiency virus (HIV) | USA | Serum | 1.50 | 1.00 | $50.00 | 55 Y | M | Black | <-70C | 21-Sep-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH15-17772 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $50.00 | 18 Y | F | White | <-70C | 01-Dec-15 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| KH16-01271 | Human immunodeficiency virus (HIV) | USA | Serum | 1.50 | 1.00 | $50.00 | 45 Y | M | White | <-70C | 04-Jan-16 | Roche Amplicor | <20 copies/mL | HIV | $50.00 | ||||||||||||||||||||||||||||
| DLS15-19184-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 31 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 3 years | 20-Aug-12 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Cough | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19185-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 21 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 16-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19186-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 19 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 20-Jul-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19187-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 26 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 2-Mar-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19188-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 30 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 2-Jan-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Respiratory Tract Infection | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19189-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 25 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 4-Jun-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Malaria | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19190-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 32 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 17-Oct-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19191-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 23 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 11-May-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19192-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 1.00 | $40.00 | 29 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 10-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19193-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 28 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 7-May-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19194-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 29 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 8 years | 10-Jun-07 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19195-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 33 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 10-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19196-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 23 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 14-Mar-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Cough | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19197-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 37 Y | M | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 17-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19198-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 28 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 11-Sep-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Malaria | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19199-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 35 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 3 years | 20-Aug-12 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | Disseminated skin rash | ||||||||||||||
| DLS15-19200-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 20 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 10-Jul-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19201-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 25 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 20-Jul-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Diarrhea | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19202-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 42 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 15 years | 13-Jul-00 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Diarrhea | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19203-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 45 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 10-Jul-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Tuberculosis | Current AIDS Related Symptoms | Unexplained loss of weight over 10% | ||||||||||||||
| DLS15-19204-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 24 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 17-Aug-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19205-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 20 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 16-Sep-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19206-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 29 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 20-Dec-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19207-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 36 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 12-Jan-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19208-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 34 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 4-Jun-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19209-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 18 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 12-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | Panadol; Amoxyl | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | Herpes Simplex | ||||||||||||||
| DLS15-19210-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 32 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 14-Aug-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Malaria | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19211-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 32 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 10-Nov-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19212-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 33 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 12-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | Coartem; Panadol | Current Co-Infections | Respiratory Tract Infection | Current AIDS Related Symptoms | Unexplained loss of weight and fever for over 1 month | ||||||||||||||
| DLS15-19213-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 38 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 10-Jun-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19214-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 29 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 4-Jul-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19215-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 22 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 11-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | Tuberculosis | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19216-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 29 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 20-Apr-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Septrin; AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19217-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 5.00 | $40.00 | 42 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 6 years | 4-Jun-09 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Malaria | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19218-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 22 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 10-Oct-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Septrin; Amoxyl; AZT; TDF; 3TC | Current Co-Infections | Cough | Current AIDS Related Symptoms | Herpes Zoster | ||||||||||||||
| DLS15-19219-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 27 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 14-Apr-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19220-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 30 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive < 1 year | 10-Apr-15 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19221-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 1.00 | $40.00 | 25 Y | F | Black | <-70C | 16-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 10-Jul-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19222-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 1.00 | $40.00 | 28 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 4-Jan-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19223-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 24 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 14-Aug-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Cough | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19224-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 4.00 | $40.00 | 22 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 20-Feb-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19225-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 28 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive New Case | 11-Nov-15 | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19226-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 38 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 10-Feb-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | Skin Rash | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19227-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 2.00 | $40.00 | 35 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 12-Jun-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19228-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 27 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 11-Jul-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19229-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 25 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 21-Apr-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19230-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 23 Y | F | Black | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 23 years | 20-Sep-94 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19231-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 32 Y | F | Black | <-70C | 11-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 6 years | 7-Jun-09 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-19232-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 3.00 | $40.00 | 23 Y | F | Black | <-70C | 12-Nov-15 | Clinical Diagnosis | HIV and AIDS | Diagnostic Status | HIV Seropositive and AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 2 years | 13-May-13 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | Fever over one month | ||||||||||||||
| DLS15-19233-V | Human immunodeficiency virus (HIV) | Uganda | Plasma | 1.00 | 1.00 | $40.00 | 34 Y | F | Black | <-70C | 10-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | STAT-PACK; Seropositive 1 year | 20-Nov-14 | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | AZT; TDF; 3TC | Current Co-Infections | None | Current AIDS Related Symptoms | No | ||||||||||||||
| DLS15-34406-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 5.00 | $40.00 | 39 Y | F | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 6 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atripla | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34407-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $40.00 | 19 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atripla | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34408-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $40.00 | 37 Y | F | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 11 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Lamivudine; Previously: Zidovudine, Kaletra | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34409-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $40.00 | 41 Y | F | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | AIDS | Diagnostic Status | AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | HPV | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34411-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $40.00 | 40 Y | M | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 4 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atazanavir; Ritonavir; Truvada | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34414-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $40.00 | 43 Y | F | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 10 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atripla | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34415-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $40.00 | 49 Y | M | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34416-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 1.00 | $40.00 | 29 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | AIDS | Diagnostic Status | AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | Meningitis, Criptococcus | Current AIDS Related Symptoms | Meningitis, Criptococcus | |||||||||||||||
| DLS15-34417-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 24 Y | F | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 4 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atazanavir; Ritonavir; Truvada | Current Co-Infections | None | Current AIDS Related Symptoms | No | Drug Resistance Testing | Mutations: K103N, K101E | |||||||||||||
| DLS15-34418-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 21 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 15 days | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34419-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 9.00 | $40.00 | 43 Y | F | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | AIDS | Diagnostic Status | AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 9 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Lopinavir; Ritonavir; Zidovuvine; Abacavir; Lamivudine | Current Co-Infections | Meningitis, Criptococcus | Current AIDS Related Symptoms | Meningitis, Criptococcus | |||||||||||||||
| DLS15-34420-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $40.00 | 45 Y | M | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 22 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atazanavir; Kivexa; Norvir | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34421-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 45 Y | F | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atripla | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34422-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $40.00 | 40 Y | F | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 3 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atripla | Current Co-Infections | Syphilis | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34424-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 31 Y | F | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 4 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Kaletra; Kivexa | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34426-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $40.00 | 38 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 3 years | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34427-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 3.00 | $40.00 | 24 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Unknown | $40.00 | Last Positive HIV Test | Seropositive 1 month | Currently Taking Anti-Retroviral Therapy? | No | Current Drug Therapy | None | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34428-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 2.00 | $40.00 | 27 Y | F | Hispanic | <-70C | 17-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atripla | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS15-34429-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 4.00 | $40.00 | 50 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | AIDS | Diagnostic Status | AIDS | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 5 years | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Atazanavir; Ritonavir; Truvada | Current Co-Infections | None | Current AIDS Related Symptoms | Herpes Zoster | |||||||||||||||
| DLS15-34430-V | Human immunodeficiency virus (HIV) | Mexico | K2 EDTA Plasma | 1.00 | 5.00 | $40.00 | 39 Y | M | Hispanic | <-70C | 18-Nov-15 | Clinical Diagnosis | HIV | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | $40.00 | Last Positive HIV Test | Seropositive 1 year | Currently Taking Anti-Retroviral Therapy? | Yes | Current Drug Therapy | Kaletra; Combivir; Tipofovir; Previously: Atripla | Current Co-Infections | None | Current AIDS Related Symptoms | No | |||||||||||||||
| DLS16-34297 | Human immunodeficiency virus (HIV) | Vietnam | Serum | 1.00 | 16.00 | $150.00 | 43 Y | M | Asian | <-70C | 04-Oct-16 | Staging | Tumor N/A; N1 | $150.00 | Menopausal Status | N/A | Smoking History | Former | 20 per day for 10 years | Date of Initial Primary Tumor Diagnosis | 21-Sep-2016 | Site of Metastasis | Lymph Nodes | History of Benign Disease Prior to Cancer Diagnosis | No | Clinical Diagnosis | Metastatic Carcinoma; HIV | Additional Information | Neck lymph node biopsy: The structure replaced by tumor tissue structures with large nuclear tumor cells, clear nuclear alkaline. Immunohistochemistry staining: tumor cells (+) to marker CK17, negative with remaining markers: CK20, P63, TTTF1, LCA, Napsin, CDX2, S100, HMB45. Conclusion: Gland carcinoma lymph node metastasis. | ||||||||||||||
| DLS16-14756 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14757 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 26 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14758 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 24 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14759 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 38 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14760 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14761 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14762 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 29 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14763 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.25 | 1.00 | $50.00 | 26 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14764 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 29 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14766 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 28 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14767 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14768 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 31 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14770 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14771 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 33 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14772 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 30 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14773 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 31 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14774 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 26 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14775 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14776 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14777 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 31 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14778 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 47 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14779 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14780 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 35 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14781 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 36 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14782 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 42 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14945 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 45 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14946 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 27 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14947 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 28 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14948 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 44 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14949 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 32 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14950 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 41 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14951 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 39 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14952 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 37 Y | F | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-14953 | Human immunodeficiency virus (HIV) | Vietnam | Plasma | 1.00 | 1.00 | $50.00 | 43 Y | M | Asian | <-70C | 30-Nov-16 | CMIA(HIV Ag/Ab Combo) | Positive | HIV | ECLIA(HIV Combi PT) | Positive | ELISA(Murex HIV Ag/Ab Combination) | Positive | $50.00 | ||||||||||||||||||||||||
| DLS16-34358 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 13.00 | $95.00 | 37 Y | F | Black | <-70C | 15-Aug-16 | Roche cobas RT-PCR | 230 copies/mL | 12-Aug-16 | Most Recent CD4 Results | 547 cells/uL | 12-Aug-16 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (1 year) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | ||||||||||
| DLS16-34376 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 5.00 | $95.00 | 35 Y | M | Black | <-70C | 15-Aug-16 | Roche cobas RT-PCR | 7,570 copies/mL | 13-Aug-16 | Most Recent CD4 Results | 521 cells/uL | 13-Aug-16 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (7 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Complera | ||||||||||
| DLS17-037883 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 22 Y | M | White | <-70C | 09-May-17 | Roche cobas RT-PCR | <20 copies/mL | 9-May-17 | Most Recent CD4 Results | 578 cells/uL | 9-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (1 year) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Gonorrhea | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | ||||||||||
| DLS17-037884 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $95.00 | 54 Y | F | Black | <-70C | 09-Mar-17 | Roche cobas RT-PCR | 390 copies/mL | 13-Mar-15 | Most Recent CD4 Results | 366 cells/uL | 9-Mar-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (26 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Reyataz Norvir Truvada | ||||||||||
| DLS17-037885 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 69 Y | F | Black | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 75 cells/uL | 6-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | AIDS / HIV Seropositive (22 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Intelence Prezista Isentress Norvir | ||||||||||
| DLS17-037886 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 12.00 | $40.00 | 54 Y | M | White | <-70C | 09-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 9-Dec-16 | Most Recent CD4 Results | 230 cells/uL | 9-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | AIDS / HIV Seropositive (19 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Stribild | ||||||||||
| DLS17-037887 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 33 Y | F | Black | <-70C | 03-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 4-Nov-16 | Most Recent CD4 Results | 582 cells/uL | 3-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (12 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Truvada Viramune | ||||||||||
| DLS17-037888 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 64 Y | M | Black | <-70C | 23-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 21-Nov-16 | Most Recent CD4 Results | 418 cells/uL | 23-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (19 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Reyataz Norvir Isentress | ||||||||||
| DLS17-037889 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 11.00 | $50.00 | 73 Y | F | Black | <-70C | 22-Mar-17 | Roche cobas RT-PCR | 60 copies/mL | 23-Dec-16 | Most Recent CD4 Results | 375 cells/uL | 22-Mar-17 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive (7 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Intelence Prezista Isentress Norvir | ||||||||||
| DLS17-037890 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 24 Y | M | Black | <-70C | 23-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 8-Dec-16 | Most Recent CD4 Results | 416 cells/uL | 23-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (1 year) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Tivicay Epzicom | ||||||||||
| DLS17-037891 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 64 Y | M | Black | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 4-Aug-16 | Most Recent CD4 Results | 632 cells/uL | 6-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (21 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Descovy Prezista Isentress Norvir | ||||||||||
| DLS17-037892 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $95.00 | 53 Y | M | Black | <-70C | 04-May-17 | Roche cobas RT-PCR | 470 copies/mL | 4-May-17 | Most Recent CD4 Results | 321 cells/uL | 4-May-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (11 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Complera | ||||||||||
| DLS17-037893 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 9.00 | $40.00 | 19 Y | M | White | <-70C | 06-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 11-Nov-16 | Most Recent CD4 Results | 802 cells/uL | 22-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (1 year) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Stribild | ||||||||||
| DLS17-037894 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $95.00 | 59 Y | F | Black | <-70C | 10-Mar-17 | Roche cobas RT-PCR | 30 copies/mL | 23-Nov-16 | Most Recent CD4 Results | 663 cells/uL | 10-Mar-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (3 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya; Previously Stribild | ||||||||||
| DLS17-037895 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 38 Y | M | White | <-70C | 22-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 3-Nov-16 | Most Recent CD4 Results | 1061 cells/uL | 22-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (3 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Syphilis | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | ||||||||||
| DLS17-037896 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 45 Y | M | Black | <-70C | 22-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 16-Dec-16 | Most Recent CD4 Results | 784 cells/uL | 31-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (8 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Kaletra Combivir | ||||||||||
| DLS17-037897 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 13.00 | $40.00 | 48 Y | M | Black | <-70C | 07-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 7-Apr-17 | Most Recent CD4 Results | 509 cells/uL | 7-Apr-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (10 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya | ||||||||||
| DLS17-037898 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 8.00 | $40.00 | 65 Y | M | White | <-70C | 29-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 5-Aug-16 | Most Recent CD4 Results | 1111 cells/uL | 29-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (14 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Sustiva Epzicom | ||||||||||
| DLS17-037899 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 12.00 | $95.00 | 37 Y | F | Black | <-70C | 12-Apr-17 | Roche cobas RT-PCR | 400 copies/mL | 12-Apr-17 | Most Recent CD4 Results | 619 cells/uL | 12-Apr-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (3 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | ||||||||||
| DLS17-037900 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 13.00 | $95.00 | 37 Y | M | White | <-70C | 08-Mar-17 | Roche cobas RT-PCR | 30 copies/mL | 19-Dec-16 | Most Recent CD4 Results | 830 cells/uL | 8-Mar-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (13 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Syphilis | Currently Taking ART | Yes | Current Drug Therapy | Tivicay Truvada | ||||||||||
| DLS17-037901 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 8.00 | $40.00 | 55 Y | M | White | <-70C | 12-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 12-Apr-17 | Most Recent CD4 Results | 324 cells/uL | 12-Apr-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (6 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Atripla | ||||||||||
| DLS17-037902 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 9.00 | $40.00 | 29 Y | M | Black | <-70C | 04-May-17 | Roche cobas RT-PCR | <20 copies/mL | 4-May-17 | Most Recent CD4 Results | 439 cells/uL | 4-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (3 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Hepatitis B | Currently Taking ART | Yes | Current Drug Therapy | Reyataz Norvir Truvada | ||||||||||
| DLS17-037903 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $40.00 | 42 Y | M | White | <-70C | 15-May-17 | Roche cobas RT-PCR | <20 copies/mL | 15-May-17 | Most Recent CD4 Results | 722 cells/uL | 15-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (15 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya | ||||||||||
| DLS17-037904 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $40.00 | 54 Y | F | Black | <-70C | 11-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 1-Sep-16 | Most Recent CD4 Results | 1974 cells/uL | 1-Sep-16 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (9 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | ||||||||||
| DLS17-037905 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $40.00 | 55 Y | F | White | <-70C | 11-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 11-Apr-17 | Most Recent CD4 Results | 561 cells/uL | 11-Apr-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (23 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Reyataz Combivir | ||||||||||
| DLS17-037906 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 40 Y | M | White | <-70C | 17-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 12-Dec-16 | Most Recent CD4 Results | 630 cells/uL | 9-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (2 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | ||||||||||
| DLS17-037907 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 12.00 | $40.00 | 45 Y | M | Black | <-70C | 31-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 31-Mar-17 | Most Recent CD4 Results | 1400 cells/uL | 31-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (13 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya; Previously Atripla | ||||||||||
| DLS17-037908 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 12.00 | $95.00 | 27 Y | M | Black | <-70C | 11-Apr-17 | Roche cobas RT-PCR | 2,724 copies/mL | 11-Apr-17 | Most Recent CD4 Results | 358 cells/uL | 11-Apr-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (5 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Stribild | ||||||||||
| DLS17-037909 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 54 Y | M | Black | <-70C | 03-May-17 | Roche cobas RT-PCR | <20 copies/mL | 3-May-17 | Most Recent CD4 Results | 1153 cells/uL | 3-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (17 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Isentress Intelence | ||||||||||
| DLS17-037910 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 22 Y | M | Black | <-70C | 06-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 6-Apr-17 | Most Recent CD4 Results | 841 cells/uL | 6-Apr-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (2 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Syphilis | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | ||||||||||
| DLS17-037911 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 47 Y | M | Black | <-70C | 23-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 25-Feb-17 | Most Recent CD4 Results | 983 cells/uL | 23-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (23 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya | ||||||||||
| DLS17-037912 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 12.00 | $40.00 | 44 Y | M | Black | <-70C | 24-May-17 | Roche cobas RT-PCR | <20 copies/mL | 24-May-17 | Most Recent CD4 Results | 114 cells/uL | 24-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | AIDS / HIV Seropositive (14 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Atripla | ||||||||||
| DLS17-037913 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 2.00 | $95.00 | 52 Y | M | Black | <-70C | 21-Mar-17 | Roche cobas RT-PCR | 36,880 copies/mL | 8-Jul-16 | Most Recent CD4 Results | 75 cells/uL | 8-Jul-16 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | AIDS / HIV Seropositive 12 years | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | ||||||||||
| DLS17-037914 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $40.00 | 55 Y | M | Black | <-70C | 24-Sep-17 | Roche cobas RT-PCR | <20 copies/mL | 28-Feb-17 | Most Recent CD4 Results | 406 cells/uL | 24-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (2 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya; Previously Stribild | ||||||||||
| DLS17-037915 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 11.00 | $40.00 | 42 Y | M | Black | <-70C | 27-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 30-Nov-16 | Most Recent CD4 Results | 502 cells/uL | 27-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (2 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Atripla | ||||||||||
| DLS17-037916 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 14.00 | $95.00 | 47 Y | F | White | <-70C | 21-Mar-17 | Roche cobas RT-PCR | 30 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 444 cells/uL | 21-Mar-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (10 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya; Previously Atripla | ||||||||||
| DLS17-037917 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 14.00 | $40.00 | 62 Y | M | Black | <-70C | 07-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 16-Sep-16 | Most Recent CD4 Results | 720 cells/uL | 7-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (21 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya; Previously Stribild | ||||||||||
| DLS17-037918 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 27 Y | M | Black | <-70C | 23-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 18-Sep-16 | Most Recent CD4 Results | 656 cells/uL | 23-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (5 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Odefsey; Previously Complera | ||||||||||
| DLS17-037921 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 14.00 | $40.00 | 59 Y | F | Black | <-70C | 23-May-17 | Roche cobas RT-PCR | <20 copies/mL | 23-May-17 | Most Recent CD4 Results | 437 cells/uL | 23-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | AIDS / HIV Seropositive (28 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Hepatitis C | Currently Taking ART | Yes | Current Drug Therapy | Genvoya | ||||||||||
| DLS17-037923 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $95.00 | 47 Y | M | Black | <-70C | 28-Mar-17 | Roche cobas RT-PCR | 98,000 copies/mL | 3-Nov-16 | Most Recent CD4 Results | 158 cells/uL | 28-Mar-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | AIDS / HIV Seropositive (16 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Tivicay Prescobix; Previously Tivicay Prezista Norvir | ||||||||||
| DLS17-037925 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $95.00 | 46 Y | F | Black | <-70C | 27-Feb-17 | Roche cobas RT-PCR | 14,160 copies/mL | 25-Nov-16 | Most Recent CD4 Results | 876 cells/uL | 27-Feb-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (11 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Truvada Evotaz | ||||||||||
| DLS17-037926 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $95.00 | 23 Y | M | White | <-70C | 20-Mar-17 | Roche cobas RT-PCR | 40 copies/mL | 17-Nov-16 | Most Recent CD4 Results | 373 cells/uL | 20-Mar-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (1 year) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | ||||||||||
| DLS17-037927 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 26 Y | M | White | <-70C | 28-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 23-Nov-16 | Most Recent CD4 Results | 568 cells/uL | 28-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (7 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya | ||||||||||
| DLS17-037928 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 47 Y | M | Black | <-70C | 21-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 14-Nov-16 | Most Recent CD4 Results | 508 cells/uL | 8-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (8 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | ||||||||||
| DLS17-037929 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 18.00 | $40.00 | 57 Y | M | Black | <-70C | 17-Apr-17 | Roche cobas RT-PCR | <20 copies/mL | 17-Apr-17 | Most Recent CD4 Results | 499 cells/uL | 17-Apr-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (9 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | ||||||||||
| DLS17-037930 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 11.00 | $40.00 | 39 Y | M | Black | <-70C | 23-May-17 | Roche cobas RT-PCR | <20 copies/mL | 23-May-17 | Most Recent CD4 Results | 433 cells/uL | 23-May-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (14 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Atripla | ||||||||||
| DLS17-037931 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 56 Y | F | Black | <-70C | 08-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 8-Oct-16 | Most Recent CD4 Results | 1873 cells/uL | 8-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (<1 year) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | ||||||||||
| DLS17-037932 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $40.00 | 51 Y | M | Black | <-70C | 20-Mar-17 | Roche cobas RT-PCR | <20 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 511 cells/uL | 20-Mar-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | AIDS / HIV Seropositive (10 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Prezcobix Viread Epzicom | ||||||||||
| DLS16-34350 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $95.00 | 36 Y | M | Black | <-70C | 03-Oct-16 | Roche cobas RT-PCR | 11,010 copies/mL | 30-Sep-16 | Most Recent CD4 Results | 275 cells/uL | 30-Sep-16 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (3 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Atripla | ||||||||||
| DLS16-34353 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 10.00 | $95.00 | 43 Y | M | Black | <-70C | 09-Jan-17 | Roche cobas RT-PCR | 5,520 copies/mL | 9-Jan-17 | Most Recent CD4 Results | 576 cells/uL | 9-Jan-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (19 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | No | Current Drug Therapy | Genvoya Previously Atripla | ||||||||||
| DLS16-34361 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 14.00 | $95.00 | 36 Y | M | Hispanic | <-70C | 23-Jan-17 | Roche cobas RT-PCR | 130 copies/mL | 21-Jan-17 | Most Recent CD4 Results | 492 cells/uL | 21-Jan-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (4 years) | Acquired Infection Category | IV Drug Abuse | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Stribild | ||||||||||
| DLS16-34363 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $95.00 | 55 Y | M | Middle Eastern | <-70C | 22-Feb-17 | Roche cobas RT-PCR | 18,610 copies/mL | 21-Feb-17 | Most Recent CD4 Results | 488 cells/uL | 21-Feb-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | Syphilis | Currently Taking ART | No | Current Drug Therapy | None currently or previously | ||||||||||
| DLS16-34365 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $95.00 | 46 Y | M | Black | <-70C | 06-Feb-17 | Roche cobas RT-PCR | 2,140 copies/mL | 3-Feb-17 | Most Recent CD4 Results | 2090 cells/uL | 3-Feb-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (16 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Isentress Truvada | ||||||||||
| DLS16-34367 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 14.00 | $95.00 | 52 Y | F | Black | <-70C | 13-Jan-17 | Roche cobas RT-PCR | 150 copies/mL | 13-Jan-17 | Most Recent CD4 Results | 385 cells/uL | 13-Jan-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (19 years) | Acquired Infection Category | IV Drug Abuse | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Complera | ||||||||||
| DLS16-34370 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 8.00 | $95.00 | 27 Y | M | Black | <-70C | 17-Feb-17 | Roche cobas RT-PCR | 630 copies/mL | 17-Feb-17 | Most Recent CD4 Results | 1311 cells/uL | 17-Feb-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (3 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Complera | ||||||||||
| DLS16-82939 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $40.00 | 56 Y | F | Black | <-70C | 23-Feb-17 | Roche cobas RT-PCR | Not detected | 13-Feb-17 | Most Recent CD4 Results | 710 cells/uL | 13-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive ( 29 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya; Previously took Stribild; Atripla | Additional Testing | None | ||||||||
| DLS16-82938 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $40.00 | 25 Y | M | Black | <-70C | 23-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 14-Feb-17 | Most Recent CD4 Results | 773 cells/uL | 14-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (4 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Odefsey;; Previously took Complera | Additional Testing | ALT: 14 IU/L; AST: 16 IU/L:Bilirubin: 0.7 mg/dL; | 14-Feb-17 | |||||||
| DLS16-82945 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 6.00 | $40.00 | 37 Y | F | Black | <-70C | 23-Feb-17 | Roche cobas RT-PCR | Not detected | 16-Feb-17 | Most Recent CD4 Results | 391 cells/uL | 16-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (16 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | Depression; Sleep disturbances | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Triumeq | Additional Testing | None | ||||||||
| DLS16-83002 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 16.00 | $40.00 | 25 Y | F | Black | <-70C | 26-Jan-17 | Roche cobas RT-PCR | <20 copies/mL | 20-Jan-17 | Most Recent CD4 Results | 565 cells/uL | 20-Jan-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (5 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Odefsey | Additional Testing | ALT: 15 IU/L; AST: 17 IU/L; ALP: 63 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.82 mg/dL; | 20-Jan-17 | |||||||
| DLS16-82994 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $40.00 | 61 Y | F | Black | <-70C | 17-Jan-17 | Roche cobas RT-PCR | Not detected | 10-Jan-17 | Most Recent CD4 Results | 919 cells/uL | 10-Jan-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (18 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | No | Current Drug Therapy | None | Additional Testing | None | ||||||||
| DLS16-82934 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 13.00 | $40.00 | 50 Y | F | Black | <-70C | 15-Feb-17 | Roche cobas RT-PCR | <20 copies/mL | 7-Feb-17 | Most Recent CD4 Results | N/A | N/A | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (27 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | Decreased appetite; Abdominal pain; Joint pain; Night sweats; Depression; Unexplained weight loss | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Tivicay Complera | Additional Testing | ALT: 32 IU/L; AST: 35 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.86 mg/dL; | 7-Feb-17 | |||||||
| DLS16-82935 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 15.00 | $95.00 | 56 Y | F | Black | <-70C | 20-Feb-17 | Roche cobas RT-PCR | 26 copies/mL | 13-Feb-17 | Most Recent CD4 Results | 416 cells/uL | 13-Feb-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (24 years) | Acquired Infection Category | Transfusion | Current AIDS Related Symptoms | Depression | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya | Additional Testing | None | ||||||||
| DLS16-82937 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $40.00 | 55 Y | F | Black | <-70C | 20-Feb-17 | Roche cobas RT-PCR | Not detected | 10-Feb-17 | Most Recent CD4 Results | 1;154 cells/uL | 10-Feb-17 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (7 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | Night sweats; Yeast infections in mouth; throat or vagina | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Tivicay Intelence | Additional Testing | ALT: 40 IU/L; AST: 36 IU/L; ALP: 93 IU/L; Bilirubin: 0.5 mg/dL; Serum Creatinine: 0.86 mg/dL; | 10-Feb-17 | |||||||
| DLS16-82943 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 12.00 | $95.00 | 51 Y | F | Black | <-70C | 28-Feb-17 | Roche cobas RT-PCR | 40 copies/mL | 27-Feb-17 | Most Recent CD4 Results | 980 cells/uL | 27-Feb-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (28 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Isentress Intelence Prezista | Additional Testing | ALT: 17 IU/L; AST: 27 IU/L; ALP: 78 IU/L; Bilirubin: 0.7 mg/dL; Cobas Ampliprep / Taqman; HCV RNA 1,161,964 IU/mL; | 3-Oct-12 | |||||||
| DLS16-82961 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 13.00 | $40.00 | 54 Y | M | Black | <-70C | 06-Jan-17 | Roche cobas RT-PCR | <20 copies/mL | 27-Dec-16 | Most Recent CD4 Results | 175 cells/uL | 27-Dec-16 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (13 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Descovy Prezcobix | Additional Testing | ALT: 24 IU/L; AST: 29 IU/L; ALP: 96 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 1.20 mg/dL; | 27-Dec-16 | |||||||
| DLS16-82981 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 17.00 | $95.00 | 51 Y | F | Black | <-70C | 27-Jan-17 | Roche cobas RT-PCR | 20 copies/mL | 17-Jan-17 | Most Recent CD4 Results | 1105 cells/uL | 17-Jan-17 | HIV Genotype Testing | N/A | N/A | $95.00 | Diagnostic Status | HIV Seropositive (9 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | Night sweats; Depression; Fatigue | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Prezista Norvir Viread Isentress | Additional Testing | ALT: 10 IU/L; AST: 12 IU/L; Bilirubin: <0.2 mg/dL; Serum Creatinine: 0.57 mg/dL; | 17-Jan-17 | |||||||
| DLS16-83006 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.00 | 4.00 | $40.00 | 48 Y | F | Black | <-70C | 03-Jan-17 | Roche cobas RT-PCR | Not detected | 27-Dec-16 | Most Recent CD4 Results | 626 cells/uL | 27-Dec-16 | HIV Genotype Testing | N/A | N/A | $40.00 | Diagnostic Status | HIV Seropositive (21 years) | Acquired Infection Category | Sexual Transmission | Current AIDS Related Symptoms | None | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | Genvoya Prezista | Additional Testing | None | ||||||||
| DLS17-048289 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 25 Y | M | White | <-70C | 21-Jun-13 | Abbott RealTime HIV-1 Viral Load | 2015 copies/mL | HIV | CD4 Result | 717 U/L | $75.00 | ||||||||||||||||||||||||||
| DLS17-048320 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $75.00 | 59 Y | F | White | <-70C | 19-Jan-10 | Roche Ultrasensitive | 257 copies/mL | HIV | CD4 Result | 672 cells/uL | $75.00 | ||||||||||||||||||||||||||
| DLS17-048292 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $40.00 | 25 Y | M | White | <-70C | 21-Jan-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 450 U/L | $40.00 | ||||||||||||||||||||||||||
| DLS17-048293 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $40.00 | 33 Y | M | White | <-70C | 30-Jan-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 620 U/L | $40.00 | ||||||||||||||||||||||||||
| DLS17-048294 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $40.00 | 29 Y | M | U/A | <-70C | 10-Feb-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 919 U/L | $40.00 | ||||||||||||||||||||||||||
| DLS17-048295 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 28 Y | M | White | <-70C | 14-Feb-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 829 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048298 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 22 Y | M | Black | <-70C | 03-Jun-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 819 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048299 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 31 Y | M | Hispanic | <-70C | 25-Jun-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 642 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048300 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 51 Y | M | White | <-70C | 27-Aug-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 814 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048301 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 33 Y | M | White | <-70C | 13-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 483 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048302 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 27 Y | M | U/A | <-70C | 13-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 584 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048303 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 44 Y | M | White | <-70C | 18-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 703 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048304 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $35.00 | 46 Y | M | U/A | <-70C | 25-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 800 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048305 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 50 Y | M | White | <-70C | 26-Sep-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 455 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048306 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $35.00 | 48 Y | M | White | <-70C | 01-Oct-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 1,239 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048307 | Human immunodeficiency virus (HIV) | USA | Serum | 1.25 | 2.00 | $35.00 | 38 Y | M | Asian | <-70C | 02-Oct-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 601 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048308 | Human immunodeficiency virus (HIV) | USA | Serum | 1.25 | 2.00 | $35.00 | 53 Y | M | Hispanic | <-70C | 04-Oct-13 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 994 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048309 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 48 Y | M | Black | <-70C | 07-Nov-13 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 1084 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048311 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 3.00 | $35.00 | 37 Y | M | U/A | <-70C | 05-Dec-14 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 556 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048312 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 29 Y | M | White | <-70C | 19-Dec-14 | Bayer HIV-1 RNA Assay V 3.0 | 40 copies/mL | HIV | CD4 Result | 662 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048314 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 2.00 | $35.00 | 66 Y | M | White | <-70C | 15-Jan-15 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 477 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048317 | Human immunodeficiency virus (HIV) | USA | Serum | 1.25 | 2.00 | $35.00 | 44 Y | M | Asian | <-70C | 05-Mar-15 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 808 U/L | $35.00 | ||||||||||||||||||||||||||
| DLS17-048319 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 2.00 | $40.00 | 54 Y | M | White | <-70C | 05-Jan-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 702 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048321 | Human immunodeficiency virus (HIV) | USA | Plasma | 5.00 | $40.00 | 50 Y | M | White | <-70C | 20-Jan-10 | Chiron 3.0 | HIV | CD4 Result | 683 cells/uL | $40.00 | ||||||||||||||||||||||||||||
| DLS17-048322 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 43 Y | M | Asian | <-70C | 27-Jan-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 753 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048324 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 44 Y | M | White | <-70C | 09-Feb-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 550 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048326 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 41 Y | M | White | <-70C | 08-Mar-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 529 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048327 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 2.00 | $40.00 | 45 Y | M | U/A | <-70C | 10-Mar-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 2083 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048328 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 56 Y | M | White | <-70C | 20-Apr-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 504 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048329 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 41 Y | M | White | <-70C | 08-Jun-10 | Roche Ultrasensitive | 40 copies/mL | HIV | CD4 Result | 520 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048330 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 42 Y | M | White | <-70C | 29-Nov-10 | Chiron 3.0 | 40 copies/mL | HIV | CD4 Result | 735 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048331 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.00 | 4.00 | $40.00 | 43 Y | M | White | <-70C | 11-Feb-11 | Abbott RealTime HIV-1 Viral Load | 40 copies/mL | HIV | CD4 Result | 658 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048332 | Human immunodeficiency virus (HIV) | USA | Plasma | 1.25 | 3.00 | $40.00 | 46 Y | M | White | <-70C | 14-Apr-11 | Chiron 1st Generation | 40 copies/mL | HIV | CD4 Result | 729 cells/uL | $40.00 | ||||||||||||||||||||||||||
| DLS17-048333 | Human immunodeficiency virus (HIV) | USA | Plasma | 5.00 | $40.00 | 64 Y | M | White | <-70C | 14-Apr-11 | Roche Ultrasensitive | HIV | CD4 Result | 498 cells/uL | $40.00 | ||||||||||||||||||||||||||||
| DLS17-048335 | Human immunodeficiency virus (HIV) | USA | Plasma | 5.00 | $40.00 | 59 Y | M | White | <-70C | 09-Jun-11 | Chiron 3.0 | HIV | CD4 Result | 390 cells/uL | $40.00 | ||||||||||||||||||||||||||||
| DLS17-048297 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 52 Y | M | Black | <-70C | 01-Apr-14 | Roche Ultrasensitive | 554 copies/mL | HIV | CD4 Result | 900 U/L | $75.00 | ||||||||||||||||||||||||||
| DLS17-048310 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 4.00 | $75.00 | 41 Y | M | White | <-70C | 15-Jul-13 | Abbott RealTime HIV-1 Viral Load | 69 copies/mL | HIV | CD4 Result | 1,357 U/L | $75.00 | ||||||||||||||||||||||||||
| DLS16-66791 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 31 Y | M | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 721 cells/uL | 1-Sep-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66794 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 42 Y | M | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 412 cells/uL | 15-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66795 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 5.00 | $50.00 | 32 Y | F | Black | <-70C | 27-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 950 cells/uL | 11-Jul-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66796 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 7.00 | $50.00 | 31 Y | M | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 1,011 cells/uL | 9-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66799 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 30 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 808 cells/uL | 22-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66802 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 6.00 | $50.00 | 34 Y | F | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 1,497 cells/uL | 16-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66804 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 26 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 22-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66806 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 40 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 692 cells/uL | 1-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66807 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 6.00 | $50.00 | 28 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 904 cells/uL | 1-Sep-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66808 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 5.00 | $50.00 | 26 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 207 cells/uL | 28-Jul-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66809 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 36 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 565 cells/uL | 27-Jul-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66810 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 7.00 | $50.00 | 43 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 207 cells/uL | 26-Jul-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66811 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 29 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 333 cells/uL | 23-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66812 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 5.00 | $50.00 | 29 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 508 cells/uL | 26-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66813 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 5.00 | $50.00 | 45 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 203 cells/uL | 15-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66814 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 7.00 | $50.00 | 21 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 555 cells/uL | 1-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66815 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 6.00 | $50.00 | 29 Y | F | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 816 cells/uL | 1-Sep-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66816 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 5.00 | $50.00 | 43 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 1-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66817 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 6.00 | $50.00 | 23 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 370 cells/uL | 15-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66818 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 7.00 | $50.00 | 27 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 944 cells/uL | 28-Jul-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66819 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 37 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 879 cells/uL | 28-Jul-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66820 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 6.00 | $50.00 | 44 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 797 cells/uL | 31-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66821 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 7.00 | $50.00 | 29 Y | F | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 726 cells/uL | 1-Sep-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66822 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 9.00 | $50.00 | 40 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 998 cells/uL | 16-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66823 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 7.00 | $50.00 | 41 Y | F | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 31-Oct-16 | Most Recent CD4 Results | 904 cells/uL | 1-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66824 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 25 Y | F | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 370 cells/uL | 24-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66825 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 8.00 | $50.00 | 19 Y | M | Black | <-70C | 26-Oct-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 27-Oct-16 | Most Recent CD4 Results | 412 cells/uL | 23-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | ||||||||||||||||||
| DLS16-66801 | Human immunodeficiency virus (HIV) | Uganda | K2 EDTA Plasma | 1.00 | 5.00 | $50.00 | 39 Y | F | Black | <-70C | 02-Nov-16 | Abbott M200 RealTime HIV-1 | <1,000 copies/mL | 2-Nov-16 | Most Recent CD4 Results | 721 cells/uL | 30-Aug-16 | HIV Genotype Testing | N/A | N/A | $50.00 | Diagnostic Status | HIV Seropositive | Acquired Infection Category | Sexual transmission | Current AIDS Related Symptoms | No | Current Co-Infections | None | Currently Taking ART | Yes | Current Drug Therapy | AZT; 3TC; ABC | ||||||||||
| DLS14-27555 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 9.00 | $50.00 | 48 Y | F | Black | <-70C | 23-Feb-15 | Siemens Trugene | PR-M36I | 11-Apr-13 | CD4 result | 125 cells/uL | Most Recent Viral Load (Roche Amplicor) | 386 copies/mL | 15-Dec-14 | $50.00 | Last Positive HIV Test | Seropositive for 11 years | 2-Jun-14 | Diagnostic Status | HIV Seropositive AIDS | Aquired Infection Category | U/A | Current AIDS Symptoms | Diarrhea; Fatigue | Current Co-Infections | Hepatitis A, B and C; HCV 1b; VL 1,918,225 | Anti-Retroviral Therapy (Currently taking ART) | Yes | Truvada; Norvir; Reyataz | |||||||||
| DLS14-27558 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 8.00 | $50.00 | 59 Y | M | White | <-70C | 23-Feb-15 | Siemens Trugene | PR-A71T | 18-Aug-14 | CD4 result | 151 cells/uL | Most Recent Viral Load (Roche Amplicor) | 591 copies/mL | 26-Jan-15 | $50.00 | Last Positive HIV Test | Seropositive for 2 years | 20-Mar-13 | Diagnostic Status | HIV Seropositive AIDS | Aquired Infection Category | U/A | Current AIDS Symptoms | No | Current Co-Infections | Toxoplasma gondii IgG - 1.7 | Anti-Retroviral Therapy (Currently taking ART) | Yes | Stribild | |||||||||
| DLS14-27587 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 8.00 | $50.00 | 51 Y | M | Black | <-70C | 23-Feb-15 | Siemens Trugene | RT-D67N, K70R, V90I, K103N, V108I, M184V, K219E, P225H | 3-Mar-11 | CD4 result | 538 cells/uL | Most Recent Viral Load (Roche Amplicor) | 204 copies/mL | 25-Nov-14 | $50.00 | Last Positive HIV Test | Seropositive for 14 years | Apr-06 | Diagnostic Status | HIV Seropositive | Aquired Infection Category | Transfusion | Current AIDS Symptoms | Neuropathy - HIV vs DM | Current Co-Infections | HCV 1a; VL 22,663,488; HAV + | Anti-Retroviral Therapy (Currently taking ART) | Yes | Stribild | |||||||||
| DLS14-27588 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 10.00 | $50.00 | 40 Y | M | Black | <-70C | 12-Mar-15 | Siemens Trugene | RT-K103N, M41L | 9-Jan-14 | CD4 result | 48 cells/uL | Most Recent Viral Load (Roche Amplicor) | 116,613 copies/mL | 5-Feb-15 | $50.00 | Last Positive HIV Test | Seropositive for 7 years | 6-Aug-08 | Diagnostic Status | HIV Seropositive AIDS | Aquired Infection Category | Sexual Transmission | Current AIDS Symptoms | No | Current Co-Infections | STI - Trep. Pall > 8.0 + | Anti-Retroviral Therapy (Currently taking ART) | Yes | Atazanavir; Truvada; Norvir | |||||||||
| DLS0054635 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 41 Y | F | Black | <-70C | 19-Aug-09 | CD4 Result | 157 cells/uL | 8-Jul-09 | Most Recent Viral Load | 287 copies/mL | 8-Jul-09 | AIDS Defining Illness Data | None | $50.00 | Date HIV Positive | 30-May-1997 | Acquired Infection Category | Heterosexual sex | Current Co-Infections | N/A | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Abacavir Atazanavir Ritonavir Truvada | ALB | ALK | ALT | AST | 3.3 g/dL | 94 U/L | 19 U/L | 18 U/L | 8-Jul-2009 | BIL | BILD | GGT | 2.8 mg/dL | 0.5 mg/dL | 199 U/L | ||||||||
| DLS0054640 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 46 Y | F | Black | <-70C | 21-Oct-09 | CD4 Result | 127 cells/uL | 22-Sep-09 | Most Recent Viral Load | 700 copies/mL | 22-Sep-09 | AIDS Defining Illness Data | Candidiasis esophageal | $50.00 | Date HIV Positive | 20-Aug-1998 | Acquired Infection Category | Injected drug use and not male sex with male | Current Co-Infections | N/A | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Atazanavir Ritonavir Truvada | ALB | ALK | ALT | AST | 2.8 g/dL | 46 U/L | 19 U/L | 36 U/L | 27-Oct-2009 | BIL | BILD | GGT | 3.2 mg/dL | 0.3 mg/dL | 27 U/L | ||||||||
| DLS0054630 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 59 Y | M | White | <-70C | 21-Jan-10 | CD4 Result | 553 cells/uL | 7-Jan-10 | Most Recent Viral Load on HIV-1 RNA Abbott m2000 Real-Time PCR | 18,060 copies/mL | 7-Jan-10 | AIDS Defining Illness Data | None | $50.00 | Date HIV Positive | 24-Jun-1993 | Acquired Infection Category | Male sex with male and not injected drug use | Current Co-Infections | N/A | Anti-Retroviral Therapy Currently Taking ART? | No | Current Drug Therapy | N/A | ALB | ALK | ALT | AST | 3.7 g/dL | 71 U/L | 43 U/L | 42 U/L | 7-Jan-2010 | BIL | BILD | GGT | 0.5 mg/dL | 0.1 mg/dL | | ||||||||
| DLS0054634 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 40 Y | M | White | <-70C | 14-Dec-10 | CD4 Result | 622 cells/uL | 23-Dec-10 | Most Recent Viral Load | 277 copies/mL | 23-Dec-10 | AIDS Defining Illness Data | None | $50.00 | Date HIV Positive | 7-Dec-1998 | Acquired Infection Category | Male sex with male and injected drug use | Current Co-Infections | HCV | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Kaletra Truvada | ALB | ALK | ALT | AST | 3.8 g/dL | 68 U/L | 41 U/L | 32 U/L | 23-Dec-2010 | BIL | BILD | GGT | 0.6 mg/dL | 0.1 mg/dL | | ||||||||
| DLS0054631 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 4.00 | $50.00 | 61 Y | F | White | <-70C | 05-Dec-11 | CD4 Result | 205 cells/uL | 21-Oct-11 | Most Recent Viral Load | 193 copies/mL | 21-Oct-11 | AIDS Defining Illness Data | Candidiasis esophageal | $50.00 | Date HIV Positive | 13-Jan-2003 | Acquired Infection Category | Injected drug use and not male sex with male | Current Co-Infections | HCV | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Atazanavir Ritonavir Tenofovir Epzicom | ALB | ALK | ALT | AST | 4.2 g/dL | 101 U/L | 26 U/L | 30 U/L | 31-Oct-2011 | BIL | BILD | GGT | 2.3 mg/dL | 0.3 mg/dL | | ||||||||
| DLS0054641 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 45 Y | M | Black | <-70C | 23-Jun-14 | CD4 Result | 261 cells/uL | 24-Jun-14 | Most Recent Viral Load | 4,377 copies/mL | 24-Jun-14 | AIDS Defining Illness Data | None | $50.00 | Date HIV Positive | 6-Feb-2004 | Acquired Infection Category | Male sex with male and not injected drug use | Current Co-Infections | N/A | Anti-Retroviral Therapy Currently Taking ART? | No | Current Drug Therapy | N/A | ALB | ALK | ALT | AST | 4 g/dL | 56 U/L | 48 U/L | 40 U/L | 24-Jun-2014 | BIL | BILD | GGT | 0.3 mg/dL | 0.1 mg/dL | | ||||||||
| DLS0054636 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 4.00 | $50.00 | 59 Y | M | Black | <-70C | 22-Oct-14 | CD4 Result | 190 cells/uL | 28-Oct-14 | Most Recent Viral Load | 44 copies/mL | 28-Oct-14 | AIDS Defining Illness Data | Candidiasis esophageal | $50.00 | Date HIV Positive | 30-Jan-2003 | Acquired Infection Category | Male sex with male and not injected drug use | Current Co-Infections | HBV | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Truvada Atazanavir Ritonavir | ALB | ALK | ALT | AST | 4.4 g/dL | 76 U/L | 28 U/L | 36 U/L | 28-Oct-2014 | BIL | BILD | GGT | 0.7 mg/dL | 0.1 mg/dL | | ||||||||
| DLS0054632 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 55 Y | F | Asian | <-70C | 04-Feb-15 | CD4 Result | 1,378 cells/uL | 3-Feb-15 | Most Recent Viral Load | 63 copies/mL | 3-Feb-15 | AIDS Defining Illness Data | None | $50.00 | Date HIV Positive | 14-Jul-2000 | Acquired Infection Category | Heterosexual sex | Current Co-Infections | N/A | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Atzanavir Ritonavir Truvada Zidovudine | ALB | ALK | ALT | AST | 4.1 g/dL | 298 U/L | 20 U/L | 22 U/L | 3-Feb-2015 | BIL | BILD | GGT | 1.3 mg/dL | <0.1 mg/dL | 33 U/L | ||||||||
| DLS0054633 | Human immunodeficiency virus (HIV) | USA | K2 EDTA Plasma | 1.50 | 2.00 | $50.00 | 53 Y | M | Black | <-70C | 16-Jan-15 | CD4 Result | 722 cells/uL | 14-Dec-14 | Most Recent Viral Load | 527 copies/mL | 15-Dec-14 | AIDS Defining Illness Data | None | $50.00 | Date HIV Positive | 24-Nov-2003 | Acquired Infection Category | Male sex with male and not injected drug use | Current Co-Infections | N/A | Anti-Retroviral Therapy Currently Taking ART? | Yes | Current Drug Therapy | Raltegravir Truvada | ALB | ALK | ALT | AST | 3.8 g/dL | 82 U/L | 10 U/L | 11 U/L | 17-Jun-2015 | BIL | BILD | GGT | 0.5 mg/dL | <0.1 mg/dL | 20 U/L | ||||||||
| KH18-14822 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 16 Y | F | Black | <-70C | 27-Mar-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-14823 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 21 Y | M | White | <-70C | 13-Mar-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-14824 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 20 Y | M | Black | <-70C | 13-Mar-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-19377 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 18 Y | M | Asian | <-70C | 24-Apr-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-19584 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 18 Y | M | Black | <-70C | 05-Apr-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-19840 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 18 Y | M | Black | <-70C | 15-May-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-21137 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 | 1.00 | $75.00 | 20 Y | M | White | <-70C | 15-May-18 | Abbott Architect | Positive | HIV | $75.00 | ||||||||||||||||||||||||||||
| KH18-22490 | Human immunodeficiency virus (HIV) | USA | Serum | 1.00 |